Federal Register #DEA-2026-0993

DEA Notice: Importer Registration Application for Controlled Substances by Veterans Pharmaceuticals, Inc.

This opportunity concerns the Drug Enforcement Administration (DEA), a component of the U.S. Department of Justice, publishing a notice about an importer registration application from Veterans Pharmaceuticals, Inc. - Government Buyer: - U.S. Department of Justice, Drug Enforcement Administration (DEA) - OEM/Vendor: - Veterans Pharmaceuticals, Inc. (applicant for importer registration) - Products/Services Requested: - Importation of basic classes of controlled substances for research and clinical trials - Substances include: - Lysergic acid diethylamide (LSD) - Marihuana Extract - Marihuana - Tetrahydrocannabinols - Mescaline - 3,4-Methylenedioxyamphetamine - 5-Methoxy-N,N-dimethyltryptamine - Dimethyltryptamine - Psilocybin - Psilocyn - Methamphetamine - No specific part numbers or quantities provided - Unique/Notable Requirements: - Registration is strictly for importation to support research and clinical trials - No authorization for import of finished dosage forms for commercial sale - DEA is soliciting public comments and objections regarding this application - OEM Highlight: - Veterans Pharmaceuticals, Inc. is the sole applicant and vendor mentioned

Description

Veterans Pharmaceuticals, Inc. has applied to be registered as an importer of basic classes of controlled substances. The application includes substances such as Lysergic acid diethylamide, Marihuana Extract, Marihuana, Tetrahydrocannabinols, Mescaline, and others. The company plans to import these controlled substances to support research and clinical trials. Comments and objections to the application can be submitted electronically or in writing before July 30, 2026.

View original listing